DIABETES Unravelling the enigma of T2DM and cardiovascular disease

被引：3
|
作者：
Bowden, Donald W. [1 ]
Cox, Amanda J. [2 ,3 ]
机构：
[1] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC 27104 USA
[2] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia
[3] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2013年 / 9卷 / 11期
关键词：
CORONARY-HEART-DISEASE;
D O I：
10.1038/nrendo.2013.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The association of type 2 diabetes mellitus with an increased risk of cardiovascular disease has been extensively documented, but the origins of this association remain largely in the realm of hypotheses. With surprisingly few insights into mechanisms of increased cardiovascular disease risk, efforts to shed new light on this important question are welcome.
引用
收藏
页码：632 / 633
页数：3
相关论文
共 50 条
  • [31] A Comparison of the Age of Diabetes Onset of T1DM and T2DM with and without a Maternal History of Diabetes
    King, Allen B.
    [J]. DIABETES, 2010, 59 : A630 - A630
  • [32] Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM?
    Zhou, Zhipeng
    Xu, Mingyue
    Xiong, Pingjie
    Yuan, Jing
    Zheng, Deqing
    Piao, Shenghua
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [33] Pioglitazone and cardiovascular risk in T2DM patients: is it good for all?
    Abdul-Ghani, Muhammad
    Jayyous, Amin
    Asaad, Nidal
    Helmy, Sherif
    Al-Suwaidi, Jassim
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (10)
  • [34] Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM)
    Urrutia-Rojas, X
    Menchaca, J
    Wadley, W
    Ahmad, N
    Lacko, A
    Bae, S
    Spellman, C
    Kudchodkar, B
    Kudolo, G
    McConathy, W
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2004, 34 (04) : 290 - 299
  • [35] ADIPOR2 genetic variants have an independent effect in susceptibility to cardiovascular disease and T2DM
    Ragia, Georgia
    Manolopoulos, Vangelis G.
    [J]. PHARMACOGENOMICS, 2012, 13 (03) : 262 - 263
  • [36] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes (T2DM)
    Kohler, Sven
    Salsali, Afshin
    Hantel, Stefan
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2015, 64 : A302 - A303
  • [37] THE PREVALENCE OF MICROALBUMINURIA IN CHILDREN WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Yafi, Michael
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A250 - A250
  • [38] DIABETES Risk of T2DM in children - influence of sleep duration
    Greenhill, Claire
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (10) : 561 - 561
  • [39] Regional effects of type 2 diabetes mellitus (T2DM) on neurodegeneration
    Moran, C.
    Phan, T. G.
    Beare, R. J.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 20 - 20
  • [40] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    A. L. Cunningham
    J. W. Stephens
    D. A. Harris
    [J]. Gut Pathogens, 13
12345